Evidence map›Paper›PMID 26937420›Full record

ArticleJournal of biological methods

Cell-based assays using calcein acetoxymethyl ester show variation in fluorescence with treatment conditions.

Fayth L Miles, Jill E Lynch, Robert A Sikes

Abstract read
In one paragraph

Article in Journal of biological methods. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach.International journal of molecular sciences · 2021
    Review
  17. Review
  18. Article
  19. Article
  20. Frontiers in physics · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fayth L MilesDepartment of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA; Laboratory for Cancer Ontogeny and Therapeutics, Department of Biological Sciences, The University of Delaware, Newark DE 19716, USA; The Center for Translational Cancer Research, The University of Delaware, Newark, DE 19716, USA.
Jill E LynchLaboratory for Cancer Ontogeny and Therapeutics, Department of Biological Sciences, The University of Delaware, Newark DE 19716, USA; The Center for Translational Cancer Research, The University of Delaware, Newark, DE 19716, USA.
Robert A SikesLaboratory for Cancer Ontogeny and Therapeutics, Department of Biological Sciences, The University of Delaware, Newark DE 19716, USA; The Center for Translational Cancer Research, The University of Delaware, Newark, DE 19716, USA.

Funding

Prostate Cancer Bone Metastasis: Biology and TargetingP01CA098912 · NCI · EMORY UNIVERSITY · PI ZAYZAFOON, MAJD · 2003 to 2019
$24.0M
UCLA CANCER EPIDEMIOLOGY TRAINING PROGRAMT32CA009142 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHANG, ZUO-FENG · 1986 to 2024
$6.3M
Sodium Channel Blockers as Inhibitors of Prostate CancerR01CA105435 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BROWN, MILTON L. · 2004 to 2008
$1.7M
NCI NIH HHS P01 CA098912NCI NIH HHS R01 CA105435NCI NIH HHS T32 CA009142
6 · The paper itself

Abstract

The use of fluorogenic compounds in cell and molecular biology has increased in both frequency and range of applications. However, such compounds may introduce artifacts in intracellular fluorescence and cell number estimations as a consequence of interaction with exogenous stimulants, necessitating the use of adequate controls for accurate measurements and valid conclusions. Using calcein acetoxymethyl ester (AM) in combination with various exogenous cellular treatments, we report that the standard practice of direct normalization of experimental values to controls is insufficient for fluorogenic measurements. Treatments applied to cells may influence intracellular conversion of the fluorogenic compound, thereby enhancing or decreasing fluorescence relative to controls. We hereby encourage caution and recommend normalization of cellular fluorescence within each treatment group before comparison to controls.

Indexed as

biochemical compoundscalceincell-based assayscellular fluorescenceprostate cancer cells

Identifiers

PMID26937420
PMCPMC4770449

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.